J. Palefsky
Joel Palefsky, M.D., C.M., F.R.C.P.(C). Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine. He is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the vice-chair of the National Cancer Institute (NCI)-supported AIDS Malignancy Consortium. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer and to identify biomarkers of progression. He is founder and past president of the International Anal Neoplasia Society and is past president of the International Papillomavirus Society. He is the founder and chairperson of the IPVS International HPV Awareness Day Campaign.
Author Of 9 Presentations
HPV Awareness Day Campaign (ID 1195)
Presenter
Lecture Time
05:00 PM - 05:00 PM
Vaccination for prevention and treatment of the immunocompromised patient: special considerations (ID 744)
Presenter
Lecture Time
04:32 PM - 04:42 PM
PERSISTENT HPV INFECTION AND RELATED ANOGENITAL DISEASE INCIDENCE AMONG MEN IN THE PLACEBO ARM OF A GLOBAL HPV VACCINE TRIAL (ID 170)
Presenter
Lecture Time
06:25 PM - 06:37 PM
RISK FACTORS ASSOCIATED WITH ANAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) IN MSM AGES 50 AND OLDER: PRELIMINARY RESULTS FROM THE AHHA STUDY. (ID 625)
Presenter
Lecture Time
06:25 AM - 06:30 AM
RISKS FACTORS FOR INCIDENT ANAL HISTOLOGIC HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HHSIL) IN WOMEN LIVING WITH HIV (WLHIV): AIDS MALIGNANCY CONSORTIUM (AMC) 084 (ID 763)
Presenter
Lecture Time
06:15 PM - 06:27 PM
Natural history of anogenital HPV infection and HPV-associated disease: data from the V501-020 study: Progression of anogenital HPV infection to disease (ID 1110)
Presenter
Lecture Time
06:25 AM - 06:35 AM
HPV INFECTION PROGRESSION AMONG MEN PARTICIPATING IN THE PLACEBO ARM OF A GLOBAL HPV VACCINE TRIAL (ID 171)
Presenter
Lecture Time
06:13 PM - 06:25 PM
Presenter of 6 Presentations
Vaccination for prevention and treatment of the immunocompromised patient: special considerations (ID 744)
Presenter
Lecture Time
04:32 PM - 04:42 PM
Natural history of anogenital HPV infection and HPV-associated disease: data from the V501-020 study: Progression of anogenital HPV infection to disease (ID 1110)
Presenter
Lecture Time
06:25 AM - 06:35 AM
HPV Awareness Day Campaign (ID 1195)
Presenter
Lecture Time
05:00 PM - 05:00 PM
HPV INFECTION PROGRESSION AMONG MEN PARTICIPATING IN THE PLACEBO ARM OF A GLOBAL HPV VACCINE TRIAL (ID 171)
Presenter
Lecture Time
06:13 PM - 06:25 PM
Moderator of 2 Sessions
Session Type
Workshop
Date
Mon, Nov 15, 2021
Session Time
04:00 PM - 04:50 PM
Chair(s)
Session Type
Featured Session
Date
Thu, Nov 18, 2021
Session Time
05:00 PM - 05:30 PM
Chair(s)